U. K. Nässander

A randomized, double‐blind, placebo‐controlled study of cd4 monoclonal antibody therapy in early rheumatoid arthritis

Peter A. Van Der Lubbe, Ben A. C. Dijkmans, Hendrik M. Markusse et al. · Arthritis & Rheumatism · 1995 · 195 citations

Acute and 2-week exposure to prednisolone impair different aspects of β-cell function in healthy men

Daniël H. van Raalte, Valentina Nofrate, Mathijs C. Bunck et al. · European Journal of Endocrinology · 2010 · 165 citations · Full text

Pharmacokinetics and Safety Study of Posaconazole Intravenous Solution Administered Peripherally to Healthy Subjects

Wendy M. Kersemaekers, Thijs van Iersel, U. K. Nässander et al. · Antimicrobial Agents and Chemotherapy · 2014 · 63 citations · Full text

Drug Safety, Same Infusion Site, Therapeutic Drug Monitoring +15

In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice.

U. K. Nässander, Peter A. Steerenberg, H. Poppe et al. · PubMed · 1992 · 60 citations

Athymic Nude Mice, Ovcar-3 Cells, Drug Targeting +15

Design of immunoliposomes directed against human ovarian carcinoma

U. K. Nässander, Peter A. Steerenberg, Wim H. de Jong et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1995 · 35 citations

Immunology, Tumor Targeting, Anti-cancer Agent +2